Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
NN Inc. $825 million sale of life sciences unit to American Securities entities
Davis Polk is advising JP Morgan Securities LLC as financial adviser to NN, Inc. in connection with the $825 million sale of…
Eli Lilly $1.1 billion notes offering
Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.1…
American Well strategic partnership with Google Cloud
Davis Polk is advising Amwell on its agreement to form a multi-year, strategic partnership with Google Cloud to deliver…
American Well strategic partnership with Google Cloud
Davis Polk is advising Amwell on its agreement to form a multi-year, strategic partnership with Google Cloud to deliver…
Comcast $4.5 billion notes offering
Davis Polk advised Comcast Corporation on its $4.5 billion SEC-registered debt offering of 1.500% notes due 2031, 2.450%…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…
Cal-Maine Foods $234 million secondary offering
Davis Polk advised the lead book-running manager and representative of the underwriters in connection with an…
Shui On Land $500 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with a $500 million Regulation S bonds offering by Shui On…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…